Crossmark

Profile of Pathogenic Mutations and Evaluation of Germline Genetic Testing Criteria in Consecutive Breast Cancer Patients Treated at a North Indian Tertiary Care Center

Crossref DOI link: https://doi.org/10.1245/s10434-021-10870-w

Published Online: 2021-10-02

Published Print: 2022-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mittal, Abhenil

Deo, S. V. S.

Gogia, Ajay

Batra, Atul

Kumar, Akash

Bhoriwal, Sandeep

Deb, Koushik Sinha

Dhamija, Ekta

Thulkar, Sanjay

Ramprasad, V. L.

Olopade, Olufunmilayo

Pramanik, Raja https://orcid.org/0000-0003-0483-6254
Funding

Funding for this research was provided by:

TATA Trusts at the University of Chicago, New Delhi Center
License Information

Text and Data Mining valid from 2021-10-02

Version of Record valid from 2021-10-02
More Information

Article History

Received: 13 July 2021

Accepted: 16 September 2021

First Online: 2 October 2021

Declarations

:

: Abhenil Mittal, SVS Deo, Ajay Gogia, Atul Batra, Akash Kumar, Sandeep Bhoriwal, Koushik Sinha Deb, Ekta Dhamija, Sanjay Thulkar, VL Ramprasad, Olufunmilayo Olopade, and Raja Pramanik declare no potential conflicts of interest.

: Informed consent was obtained from all patients.

: Data regarding this study will be available from the corresponding author (RP) upon reasonable request.

: The study protocol was approved by the IEC, vide letter number IECPG-35/23.01.2019

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below